Day: September 5, 2023

Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Third Quarter Common Stock Distribution of $0.1238 Per Share

TORONTO, Sept. 05, 2023 (GLOBE NEWSWIRE) — Sprott Focus Trust, Inc. (Nasdaq-FUND) (the “Fund” or “FUND”) has declared a quarterly distribution of $0.1238 per share on its Common Stock. The distribution, optionally payable in additional shares of Common Stock or in cash by specific stockholder election, is to be paid on September 29, 2023 to stockholders of record at the close of business on September 15, 2023 (ex-dividend on September 14, 2023). The price of shares issued for reinvestment will be determined on September 22, 2023. The Fund currently has adopted a Distribution Policy of paying quarterly distributions on its Common Stock. Distributions are being made at the annual rate of 6% of the rolling average of the prior four calendar quarter-end net asset values (“NAVs”), with the fourth quarter distribution being the greater...

Continue reading

HealthEquity Reports Second Quarter Ended July 31, 2023 Financial Results

Delivers Record HSA Asset Growth, Margin Expansion Highlights of the second quarter include: Revenue of $243.5 million, an increase of 18% compared to $206.1 million in Q2 FY23. Net income of $10.6 million, compared to net loss of $10.7 million in Q2 FY23, with non-GAAP net income of $45.6 million, an increase of 62% compared to $28.1 million in Q2 FY23. Net income per diluted share of $0.12, compared to net loss per diluted share of $0.13 in Q2 FY23, with non-GAAP net income per diluted share of $0.53, compared to $0.33 in Q2 FY23. Adjusted EBITDA of $88.1 million, an increase of 31% compared to $67.0 million in Q2 FY23. 8.2 million HSAs, an increase of 9% compared to Q2 FY23. Total HSA Assets of $23.2 billion, an increase of 13% compared to Q2 FY23. 15.0 million Total Accounts, including both HSAs and complementary CDBs, an increase...

Continue reading

DBV Technologies to Participate in Upcoming Investor Conference

Montrouge, France, September 5, 2023 DBV Technologies to Participate in Upcoming Investor Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced the company will participate in the H.C. Wainwright Annual Global Investment Conference taking place on September 11th −13th in New York, NY. Daniel Tassé, Chief Executive Officer, will represent the company in a fireside chat session on Tuesday, September 12th at 4:00 pm EST, as well as one-on-one investor meetings throughout the day. A live webcast of the presentation will be available on the Investors & Media section of the Company’s website: https://journey.ct.events/view/4f45c9c0-d6f0-4fe2-a5b2-ffc6be420349. A replay will also be available on DBV Technologies’ website for 90 days after...

Continue reading

Nyxoah to Participate in Upcoming Investor Conferences

Nyxoah to Participate in Upcoming Investor Conferences Mont-Saint-Guibert, Belgium – September 5, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in two upcoming investor conferences in New York City. Olivier Taelman, Nyxoah’s Chief Executive Officer, will deliver corporate updates at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023, at 1:30pm EST and the Baird Global Healthcare Conference on Wednesday, September 13, 2023, at 12:15pm EST. Webcasts of the presentations will be available on the Events section of Nyxoah’s Investor Relations website. The...

Continue reading

Palomar Holdings, Inc. Announces Participation in the Barclays Global Financial Services Conference

LA JOLLA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ: PLMR) (“Palomar”) today announced that Mac Armstrong, Chairman and Chief Executive Officer, and Chris Uchida, Chief Financial Officer, will participate in a fireside chat at the Barclays Global Financial Services Conference on Tuesday, September 12, 2023 at 10:30 a.m. Eastern Time. Interested investors and other parties can access a live webcast of the presentation by visiting the Investor Relations section of Palomar’s website at https://ir.palomarspecialty.com/. An online replay will be available on the same website following the presentation. Management will also be available for one-on-one and small group meetings with investors. About Palomar Holdings, Inc.Palomar Holdings, Inc. is the holding company of subsidiaries Palomar Specialty Insurance...

Continue reading

Global DevSecOps Report on AI Shows Cybersecurity and Privacy Concerns Create an Adoption Dilemma

2023 Global DevSecOps Report: The State of Al in Software Development GitLab 2023 Global DevSecOps Report: The State of Al in Software Development GitLab survey finds organizations are optimistic about AI, but AI adoption requires attention to privacy and security, productivity, and training 83% of those surveyed said that implementing AI in their software development processes is essential to avoid falling behind, however 79% noted they are concerned about AI tools having access to private information or intellectual property 40% of all respondents cited security is already a key benefit of AI, but 40% of security professionals surveyed were concerned that AI-powered code generation will increase their workload 90% of participants reported using AI in software development or plan to, while 81% said they need more training...

Continue reading

NANOBIOTIX Strengthens Global Development Capabilities With the Appointment of Veteran Industry Leader Dr. Louis Kayitalire as Chief Medical Officer

PARIS and CAMBRIDGE, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the “Company”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced the appointment of Louis Kayitalire, MD, as chief medical officer. Dr. Kayitalire brings an exceptional biopharmaceutical industry track record with proven success in the research, development, registration, and commercialization of therapeutics in oncology. “We are pleased to welcome Dr. Kayitalire to our executive leadership team at this pivotal moment for the development and commercialization of potential first-in-class radioenhancer NBTXR3,” said Laurent Levy, Nanobiotix co-founder and chairman of the executive board. “Given the disruptive potential of...

Continue reading

Maravai LifeSciences to Host 2023 Investor R&D Day

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that it will host its 2023 Investor R&D Day on Thursday, September 28, starting at 10 a.m. ET in New York City. The format will feature presentations by Trey Martin, Chief Executive Officer, and other members of Maravai’s senior leadership team and conclude with a Q&A session. You can access the live webcast of the presentation via the Investors section of our website, www.maravai.com. A replay of the webcast will be available following the presentation. About MaravaiMaravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines...

Continue reading

Super League Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference

SANTA MONICA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLGG), a global leader in providing immersive experiences across the world’s largest metaverse gaming platforms, today announced management’s participation in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13 virtually and at the Lotte New York Palace Hotel in New York City. The Company’s Chief Executive Officer, Ann Hand, and Chief Financial Officer, Clayton Haynes, will be available for virtual one-on-one meetings with investors. To schedule a meeting with Super League’s management, please contact your conference representative or you may also email your request to SLGG@mzgroup.us. The Company will also be giving an on-demand presentation that will be available to conference attendees beginning Monday September...

Continue reading

Vimeo to Present at Piper Sandler Growth Frontiers Conference

Future Conference Participation to be Announced on Investor Relations Website NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) — Vimeo will attend the Piper Sandler Growth Frontiers Conference on September 13, 2023. Chief Financial Officer of Vimeo, Gillian Munson, will participate in a fireside chat at 9:30 a.m. CT. A live audiocast of this event will be available to the public at https://www.vimeo.com/investors. Going forward, Vimeo’s participation in investor events will be announced on its Investor Relations site, https://www.vimeo.com/investors where visitors can also sign up to receive email alerts for future events. Live webcasts and replays of presentations, company filings, and safe harbor disclosure information can also be found there. About Vimeo Vimeo (NASDAQ:VMEO) is the world’s most innovative video experience platform....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.